Delivery Order SPE2DB22D2206-SPE2DB25FJT73
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $2,607.02. This is a non-set-aside, competitively awarded firm fixed-price delivery order with an ultimate completion date of September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) valued at $2,984.62. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.47 to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (quantity: 100s) on September 8, 2025, with completion scheduled for September 9, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 100 capsules of Adderall XR 30 mg, with a contract ceiling value of $1,848.25. This competitively awarded, non-set-aside delivery order has a firm fixed price structure and is scheduled for completion by September 22, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) valued at $1,595.93. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 16, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,388.24 for 100 capsules of Adderall XR 30 mg on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's larger contractual...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall XR 15 mg capsules (100-count units) with a ceiling value of $5.38K. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 30 mg capsules (quantity: 100s) valued at $2,232.71. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents performance at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 10 mg capsules in quantities of 100 units, with a contract ceiling value of $1,194.12. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The award supports federal medical procurement needs, with performance of work occurring...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJT73Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Adderall XR 30 mg capsules (quantity: 100 units) with a ceiling value of $1,759.80. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract calls for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply needs for military healthcare programs. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement and supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting activity demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains and transaction values, ranging from small orders to substantial contracts exceeding $45,000. The DLA is planning future Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among qualified contractors to support ongoing military and federal healthcare supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/4/25 |